Moreover, OTUD7B upregulation was appeared to predict an increased risk for cancer recurrence/metastasis in breast cancer patients who may exhibit a poor pathologic complete response to paclitaxel chemotherapy. The gene discussed is OTUD7B; the disease is cancer.